Eli Lilly & Co. (LLY) Stock Price Today—Real Time Charts and Quotes

Q: What's the stock price of Eli Lilly & Co. (LLY) today?

Eli Lilly & Co. (LLY) is currently trading at $988.87, with a 24h change of +2.16%. The 52-week trading range is $623.78–$1,133.95.

Q: What are the 52-week high and low prices for Eli Lilly & Co. (LLY)?

LLY has a 52-week high of $1,133.95 and a 52-week low of $623.78, with the current price at $988.87.

Q: What is the price-to-earnings (P/E) ratio of Eli Lilly & Co. (LLY)? What does it indicate?

The current P/E ratio (TTM) of LLY is 46.760866416323054, indicating how much investors pay for each dollar of earnings. A higher P/E ratio often reflects stronger growth expectations, while a lower P/E ratio may suggest a more attractive valuation or slower growth. Comparing it with the average P/E of the Drug Manufacturers - General industry for a better context.

Q: What is the market cap of Eli Lilly & Co. (LLY)?

Eli Lilly & Co. (LLY) currently has a market cap of approximately $933.66B.

Q: What is the most recent quarterly earnings per share (EPS) for Eli Lilly & Co. (LLY)?

Eli Lilly & Co. (LLY)'s diluted earnings per share (Diluted EPS) is 28.25600894354388. EPS = Net Income / Total Diluted Shares, which is a key metric for measuring a company's profitability.

Q: Should you buy or sell Eli Lilly & Co. (LLY) now?

As of now, LLY is trading at $988.87, with a P/E ratio of 46.760866416323054 and a diluted EPS of 28.25600894354388. Your buy or sell decisions should be based on your investment goals and risk tolerance. We recommend making an overall judgment by considering Eli Lilly & Co.'s financial reports, the outlook of the Drug Manufacturers - General sector, and your own holdings. Investing involves risk—please make decisions prudently.

Q: What factors can affect the stock price of Eli Lilly & Co. (LLY)?

Key factors include: company quarterly reports (revenue, EPS), competition and trends in the Drug Manufacturers - General sector, macroeconomic environment (interest rate, inflation), market sentiment, as well as major events like product releases and mergers & acquisitions.

Q: How to buy Eli Lilly & Co. (LLY) stock?

You can buy Eli Lilly & Co. (LLY) through Gate. Sign up for a Gate account and complete identity verification, then go to the Eli Lilly & Co. trading page to make a purchase. Gate supports fractional share trading, so you can start investing without buying a whole share.

$988,87

+$20,94(+2,16 %)

*Data last updated: 2026-05-06 02:35 (UTC+8)

As of 2026-05-06 02:35, Eli Lilly & Co. (LLY) is priced at $988,87, with a total market cap of $933,66B, a P/E ratio of 46,76, and a dividend yield of 0,63 %. Today, the stock price fluctuated between $964,50 and $992,80. The current price is 2,52 % above the day's low and 0,39 % below the day's high, with a trading volume of 598,15K. Over the past 52 weeks, LLY has traded between $623,78 to $1.133,95, and the current price is -12,79 % away from the 52-week high.

LLY Key Stats

Yesterday's Close$967,93

Market Cap$933,66B

Volumen598,15K

P/E Ratio46,76

Dividend Yield (TTM)0,63 %

Dividend Amount$1,73

Diluted EPS (TTM)28,25

Net Income (FY)$20,63B

Revenue (FY)$65,17B

Earnings Date2026-08-06

EPS Estimate8,65

Revenue Estimate$20,23B

Shares Outstanding964,59M

Beta (1Y)0.504

Ex-Dividend Date2026-02-13

Dividend Payment Date2026-03-10

About LLY

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

SectorHealthcare

IndustryDrug Manufacturers - General

CEODavid A. Ricks

HeadquartersIndianapolis,IN,US

Official Websitehttps://www.lilly.com

Employees (FY)50,00K

Average Revenue (1Y)$1,30M

Net Income per Employee$412,76K

Erfahren Sie mehr über Eli Lilly & Co. (LLY)

Gate Learn Articles

Ist XRP eine gute Investition? Ein umfassender Leitfaden zu seinem Potenzial

Fragen Sie sich, ob XRP eine gute Investition ist? Entdecken Sie seine Vorteile, Risiken, Marktleistung und Experteneinblicke, um Ihnen bei der Entscheidung im Jahr 2025 zu helfen.

2025-02-25

XRP Preisvorhersage: Analyse zukünftiger Trends und Investitionsmöglichkeiten

Dieser Artikel wird sich mit der Preisvorhersage von Ripple XRP befassen, die möglichen Preisentwicklungen von XRP in der Zukunft analysieren und wertvolle Referenzen für Investoren bezüglich der XRP-Investition durch die Kombination von Markttrends, Trumps Politik und makroökonomischen Faktoren bereitstellen. Sowohl kurzfristige Händler als auch langfristige Investoren können nützliche Informationen daraus gewinnen.

2025-03-17

Erkundung von Avalon Labs: Aufbau des zukünftigen Finanzhubs von Bitcoin

Avalon Labs fördert aktiv die Finanzialisierung von Bitcoin und baut ein nahtloses, transparentes und skalierbares Finanzökosystem auf. Ihre innovativen Dienstleistungen wie Bitcoin-gedeckte Kredite, Stablecoins, ertragsgenerierende Konten und Kreditkarten zielen darauf ab, Bitcoin zu einem aktiven Wirtschaftsgut auf dem globalen Markt zu machen. Dieser Artikel wird die Kernfunktionen, technischen Vorteile und Marktaussichten von Avalon Labs im Detail erläutern und den Lesern helfen, dieses Projekt vollständig zu verstehen, das das Finanzökosystem neu gestaltet.

2025-02-12

Eli Lilly & Co. (LLY) FAQ

What's the stock price of Eli Lilly & Co. (LLY) today?

Eli Lilly & Co. (LLY) is currently trading at $988,87, with a 24h change of +2,16 %. The 52-week trading range is $623,78–$1.133,95.

What are the 52-week high and low prices for Eli Lilly & Co. (LLY)?

What is the price-to-earnings (P/E) ratio of Eli Lilly & Co. (LLY)? What does it indicate?

What is the market cap of Eli Lilly & Co. (LLY)?

What is the most recent quarterly earnings per share (EPS) for Eli Lilly & Co. (LLY)?

Should you buy or sell Eli Lilly & Co. (LLY) now?

What factors can affect the stock price of Eli Lilly & Co. (LLY)?

How to buy Eli Lilly & Co. (LLY) stock?

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.